At the 59th European Association for the Study of Diabetes in Germany, an expert panel discussed the tremendous cardiovascular health benefits of limiting body weight...

The newest study of once-weekly insulins showed that insulin icodec led to similar reductions in A1C and similar time in range compared to once-daily Tresiba (degludec).

Here are our top stories from September 2023. This month’s best stories cover a wide variety of topics like upcoming therapies, new research findings, and more.

Lauren Bongiorno, a diabetes coach and person living with type 1 diabetes, shares her top strategies for managing diabetes while traveling or stepping outside your daily...

Join clinical trial NCT05018585 investigating Diamyd's impact on people recently diagnosed with type 1 diabetes. The investigational drug could be a game-changer in...

Manage diabetes better with the latest ADA standards for glucose, cholesterol, and blood pressure. Discuss your targets with your healthcare team for personalized care.

Explore timeinrange.org: the go-to website for resources on time in range for healthcare professionals, caregivers, and people with diabetes. Elevate care with tools,...

Diabetes technology revolutionizes type 1 diabetes management. Discover how CGMs and AID systems enhance glycemic control and ease daily burdens.

Managing your Time in Range (TIR) can be challenging, but there are several apps you can download to help you. In this article, we cover 14 apps you may want to check...

Uncover phase 2 clinical trial results of CagriSema, a promising diabetes treatment showing improvements in A1C, weight loss, and time in range.

A lot has happened this year advancing time in range as a primary glucose metric in diabetes care globally. Though we aren’t there yet, a panel shared their thoughts on...

Clinical trial results have shown that once-weekly basal insulins are just as effective at reducing A1C as once-daily insulin.

Tandem Diabetes announced clinical trial results that showed from the very first day, children with type 1 diabetes who used the Control-IQ hybrid closed loop technology...

You have probably heard of time in range (TIR), but time in tight range (TITR) has slowly become popular among some diabetes experts. Whereas guidelines generally define...

Access to continuous glucose monitors (CGM) can be severely limited. Tamara Oser, a researcher at the University of Colorado, launched PREPARE 4 CGM, a project to...

What’s an AGP report, and what does it show? Why does my AGP matter? How can I use an AGP report to improve my blood glucose levels and time in range?

Leading endocrinologist Prof. Thomas Danne spoke with diaTribe about how he uses time in range in his practice and shared his best tips for people living with diabetes.

diaTribe and the Time in Range Coalition, in a global effort to raise the awareness and adoption of Time in Range and the use of continuous glucose monitors (CGM),...

Telehealth visits skyrocketed during the pandemic, as did the demand for at-home A1C tests. They are convenient and quick, but how accurate are they? And should they be...

What does it mean to experience hyperglycemia and hypoglycemia? How can you recognize the symptoms of both, intervene early, and prevent serious episodes of high and low...